British Dragon
British Dragon
Halotestex 10 mg
Product Information
Compound Details
Active Substance
Fluoxymesterone
17α-Alkylated Oral Anabolic Steroid
10 mg
Strength
10 mg/tablet
Package
50 Tablets
Form
Oral Tablets
Drug Class
Anabolic-Androgenic Steroid
Estimated Half-Life
Approximately 9 Hours
Manufacturer
British Dragon
Shipping :
International
U.S. Domestic
Out of stock
- Overview
- Profile
- Usage
- Safety
- Shipping
- Storage
- FAQ
- Reviews
Product Overview
Halotestex 10 mg by British Dragon
Halotestex 10 mg is an oral fluoxymesterone tablet manufactured by British Dragon and dosed at 10 mg per tablet, supplied in packs of 50 tablets.
Fluoxymesterone Oral
Halotestex 10 mg contains fluoxymesterone, a potent synthetic oral anabolic-androgenic steroid and 17α-alkylated derivative of testosterone. It was developed in the 1950s and approved by the FDA in 1956 for medical use. Fluoxymesterone has a relatively high ratio of androgenic to anabolic activity, similar to testosterone, and a long elimination half-life of approximately 9.2 hours.
In clinical medicine, fluoxymesterone was historically prescribed for male hypogonadism, delayed puberty in boys, and palliation of inoperable breast cancer in women. Medical use has declined substantially because of its hepatotoxicity and the availability of safer alternatives. The standard clinical dosage for male hypogonadism is 5 to 20 mg daily, while breast cancer palliation uses 10 to 40 mg daily in divided doses.
In non-medical bodybuilding and strength-sport contexts, fluoxymesterone is commonly referenced for its ability to produce rapid, significant increases in strength and aggression without proportional muscle mass gains. Its androgenic effects on the central nervous system stimulate motor unit recruitment and neural drive, making it popular among powerlifters and strength athletes for peaking before competition. Such use falls outside approved indications and carries substantial risks of liver toxicity, dyslipidemia, and cardiovascular strain.
Key Properties of Halotestex 10 mg
- Potent 17α-alkylated oral androgen with high androgenic-to-anabolic ratio
- Produces rapid strength gains disproportionate to muscle mass increases
- Does not aromatize, avoiding water retention and gynecomastia
- Elimination half-life of approximately 9.2 hours
- 50 tablet pack size supports short-cycle research protocols
Product Profile
Fluoxymesterone Profile
Fluoxymesterone is a 17α-alkylated oral androgen with a high androgenic-to-anabolic ratio, producing rapid strength gains but carrying significant hepatotoxicity risks.
17α-Alkylated Oral Androgen
Fluoxymesterone is a synthetic derivative of testosterone modified with a fluorine atom at position 9 and a methyl group at position 17. The 17α-alkylation allows the compound to survive first-pass metabolism in the liver, enabling oral bioavailability. However, this structural modification is also responsible for the compound's significant hepatotoxicity, as 17α-alkylated androgens are associated with cholestatic jaundice, liver function abnormalities, and rarely hepatocellular neoplasms and peliosis hepatis.
The drug binds to androgen receptors in various tissues, triggering increased protein synthesis and nitrogen retention in muscle tissue. It also stimulates erythropoiesis, increasing red blood cell production and oxygen delivery to muscles. Unlike testosterone, fluoxymesterone does not aromatize to estrogen, which means it does not cause water retention or gynecomastia.
A defining characteristic of fluoxymesterone in performance contexts is its disproportionate effect on strength relative to muscle mass. Its androgenic activity on the central nervous system increases motor neuron excitability and neural drive, producing strength gains that exceed the visible muscle growth. This makes it particularly sought after in powerlifting and strength sports where absolute force production is prioritized over hypertrophy.
Clinical Status
FDA-Approved Historically — Now Rarely Used
Fluoxymesterone was FDA-approved in 1956 for hypogonadism, delayed puberty, and breast cancer palliation. Its use has declined dramatically due to hepatotoxicity and the availability of safer alternatives. It remains available only as a discontinued or rarely prescribed medication.
Halotestex 10 mg vs Other British Dragon Preparations
British Dragon offers several anabolic compounds with distinct characteristics. Oxanabol contains oxandrolone, a milder oral with a more favorable safety profile. Stanabol 10 is a non-17α-alkylated oral with lower liver toxicity. For injectable options, Testabol Propionate provides a short-acting testosterone ester.
Fluoxymesterone's distinguishing characteristic among these compounds is its extreme androgenic potency and narrow therapeutic window. It is generally considered among the most hepatotoxic oral steroids, second only to methyltrienolone.
Dosage & Usage
Halotestex 10 mg Dosage & Usage
The information below is provided for educational reference only. Fluoxymesterone is a prescription androgen; medical use requires appropriate diagnosis and supervision. Non-medical use falls outside approved indications.
Typical Dosage Ranges
In clinical practice, fluoxymesterone dosing was individualized based on the condition being treated. For male hypogonadism, the recommended dose was 5 to 20 mg daily. For delayed puberty in boys, 2.5 to 10 mg daily for limited duration. For breast cancer palliation, 10 to 40 mg daily in divided doses.
In non-medical bodybuilding contexts, fluoxymesterone is commonly referenced at 10 to 20 mg daily for 2 to 4 weeks, typically before competition. Community discussions emphasize that 10 mg daily is considered a minimal dose, with some users reporting that lower doses are ineffective.
| Use Case | Common Reference Range | Frequency |
|---|---|---|
| Clinical (male hypogonadism) | 5–20 mg | Daily, single or divided doses |
| Clinical (breast cancer palliation) | 10–40 mg | Daily in divided doses |
| Non-medical (strength peaking) | 10–20 mg | Daily for 2–4 weeks |
These non-medical ranges represent community-reported practices and are not derived from controlled clinical trials for performance enhancement. The narrow therapeutic window and severe hepatotoxicity mean that even short-term use at these doses carries significant risks.
Stacking & Cycle Considerations
In non-medical strength-sport contexts, fluoxymesterone is typically used as a standalone "peaking" compound in the final 2–4 weeks before competition rather than as a base cycle compound. Its lack of aromatization and inability to support meaningful muscle hypertrophy mean it is not used for bulking cycles.
Fluoxymesterone should not be stacked with other 17α-alkylated oral steroids, as this compounds hepatotoxicity. Combining with injectable compounds like Testabol Depot may be referenced in some protocols, but the oral's primary role remains strength and aggression support rather than anabolic growth.
Managing Side Effects
Fluoxymesterone carries substantial risks that require monitoring. Liver toxicity is the primary concern, with potential for cholestatic jaundice, elevated transaminases, and rarely hepatocellular neoplasms and peliosis hepatis. Liver function tests should be obtained periodically during clinical use.
Dyslipidemia is severe, with HDL cholesterol dropping 30–50% within weeks and LDL rising. Cardiovascular risk accumulates easily, and polycythemia develops reliably with hematocrit increases. Complete hypothalamic-pituitary-gonadal axis shutdown occurs, requiring post-cycle therapy with Clomiphene or Tamoxifen after use.
Important
Individual Response Varies
Fluoxymesterone has no approved use for performance enhancement. Any information about non-medical use is derived from user-reported practices and is not validated by controlled clinical research. This information does not constitute medical advice.
Safety & Information
Fluoxymesterone Safety Information
Fluoxymesterone is a potent 17α-alkylated androgen with significant hepatotoxicity and cardiovascular risks. Medical use requires clinical oversight, and non-medical use falls outside approved indications.
Important Safety Information
Fluoxymesterone is contraindicated in pregnancy (Category X), in men with prostate or male breast cancer, and in patients with severe liver disease. It should not be used in women who may become pregnant due to risk of fetal harm and virilization.
The 17α-alkylated structure confers significant hepatotoxicity. Liver function tests should be obtained periodically during clinical use. Post-marketing reports include cholestatic jaundice, alterations in liver function tests, and rarely hepatocellular neoplasms and peliosis hepatis.
Important
Non-Medical Use
Non-medical use of fluoxymesterone falls outside approved indications and carries substantial risks. The compound is among the most hepatotoxic oral steroids, and product purity does not establish that non-medical use is safe or appropriate for an individual.
Potential Adverse Effects
Hepatotoxicity is the primary adverse effect of fluoxymesterone. Manifestations include cholestatic jaundice, elevated transaminases, and rarely hepatocellular neoplasms and peliosis hepatis. Liver function abnormalities may develop with long-term use.
Cardiovascular effects include severe dyslipidemia with HDL cholesterol dropping 30–50% and LDL rising, hypertension, and polycythemia with increased hematocrit and clot risk. Sodium and water retention may occur and can worsen congestive heart failure in patients with pre-existing cardiac, liver, or kidney disease.
Endocrine effects include complete hypothalamic-pituitary-gonadal axis shutdown, testicular atrophy, oligospermia, and decreased fertility in males. Women may experience virilization including deepening of the voice, clitoral enlargement, and menstrual irregularities.
Conditions Requiring Medical Evaluation
Fluoxymesterone is not appropriate for everyone. Contraindications include pregnancy, prostate cancer, male breast cancer, and severe liver disease. Caution is advised in patients with pre-existing heart conditions, fluid retention, or benign prostatic hypertrophy, as acute urethral obstruction may develop.
Patients should inform their physician of any pre-existing conditions including chicken pox, heart disease, kidney disease, liver disease, or lung disease, as these may worsen with fluoxymesterone treatment.
Monitoring During Therapy
Clinical monitoring for fluoxymesterone includes periodic liver function tests, hemoglobin and hematocrit levels to detect polycythemia, and serum cholesterol. Women with disseminated breast carcinoma should have frequent determination of urine and serum calcium levels during androgen therapy.
Patients should report nausea, vomiting, changes in skin color, and ankle swelling. Males should report too frequent or persistent erections, and females should report hoarseness, acne, changes in menstrual periods, or increased facial hair.
Product Care
Storage & Handling
Store tablets in a cool, dry place in the original packaging. Keep out of reach of children. Inspect tablets before use and do not use if they appear damaged or compromised.
Further Safety Information
Shipping & Authenticity
Shipping & Product Authenticity
Halotestex 10 mg is supplied through the official British Dragon distribution chain and shipped in original manufacturer packaging with discreet, privacy-focused handling.
USA Domestic 3–5 business days
International 10–15 business days
Order Processing 24–48 business hours
Tracking Provided after dispatch
Direct Supply
Discreet Delivery & Original Packaging
The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details. Products are supplied through the official British Dragon distribution chain.
What to Expect
- Orders are processed after payment confirmation
- USA Domestic shipping is typically faster when local stock is selected
- International orders include tracking, though update frequency may vary by destination
- Multiple warehouses may result in separate shipments when applicable
Authenticity Verification
To verify your Halotestex 10 mg product, use the security code on the packaging and cross-check it on the British Dragon official site. Official British Dragon presentation and original packaging help reinforce product legitimacy and buyer confidence.
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Storage
Halotestex 10 mg Storage
Proper storage conditions help preserve tablet stability and overall product integrity throughout shelf life.
Recommended Conditions
Store at controlled room temperature (15–25°C) in a cool, dry place, away from direct light and moisture. Keep tablets in their original blister packaging or container until use to protect from humidity.
Inspect tablets before use and do not use if they appear discolored, cracked, or otherwise compromised. Keep out of reach of children.
Quick Reference
Do & Don't
- Do store at 15–25°C
- Do keep in original packaging
- Do inspect before each use
- Don't expose to direct sunlight or moisture
- Don't store in bathroom or humid areas
- Don't use if tablets appear abnormal
Frequently Asked Questions
Halotestex 10 mg FAQ
Answers to common questions about Halotestex 10 mg, the Fluoxymesterone compound, and its applications.
What is Halotestex 10 mg used for?
Halotestex 10 mg contains fluoxymesterone, a potent oral androgen. In clinical medicine, it was historically used for male hypogonadism, delayed puberty, and breast cancer palliation. In non-medical strength-sport contexts, it is commonly referenced for rapid strength gains and aggression, though such use falls outside approved indications.
How often should Halotestex 10 mg be taken?
Clinical dosing ranged from 5 to 20 mg daily for hypogonadism and 10 to 40 mg daily for breast cancer. In non-medical contexts, 10 to 20 mg daily for 2 to 4 weeks is commonly referenced. These non-medical practices are not derived from controlled clinical trials.
Does Halotestex 10 mg require PCT?
Fluoxymesterone causes complete hypothalamic-pituitary-gonadal axis shutdown, suppressing endogenous testosterone production. Post-cycle therapy is commonly referenced after use to restore natural testosterone production. Agents such as Clomiphene or Tamoxifen are typically referenced for this purpose.
What does Fluoxymesterone do?
Fluoxymesterone binds to androgen receptors, triggering increased protein synthesis and nitrogen retention in muscle tissue. It also stimulates erythropoiesis and increases motor neuron excitability, producing strength gains disproportionate to muscle mass increases. It does not aromatize, so it does not cause water retention or gynecomastia.
How long does Halotestex take to work?
Fluoxymesterone has an elimination half-life of approximately 9.2 hours. Users may notice strength and aggression effects within days of starting use. However, the compound is typically used in short 2–4 week cycles due to hepatotoxicity risks.
Is Fluoxymesterone the best strength steroid?
There is no universally established "best" strength steroid, and fluoxymesterone has not been validated in controlled trials for performance outcomes. It is known for producing rapid strength gains without proportional muscle growth. However, its extreme hepatotoxicity makes it one of the riskiest oral steroids.
What is the difference between Halotestex and Oxanabol?
Halotestex and Oxanabol have different potency and safety profiles. Fluoxymesterone is far more androgenic and hepatotoxic, while oxandrolone is milder with a more favorable safety profile. Fluoxymesterone is used for strength peaking, while oxandrolone is more commonly referenced for lean mass preservation.
What is the difference between Halotestex and Stanabol 10?
Halotestex and Stanabol 10 are both oral steroids but differ significantly. Fluoxymesterone is a 17α-alkylated androgen with extreme hepatotoxicity, while stanozolol has lower liver toxicity. Fluoxymesterone produces strength without size, while stanozolol is often referenced for hardness and vascularity.
Is 10 mg of Halotestex a lot?
Halotestex 10 mg is labeled at 10 mg of fluoxymesterone per tablet. This is within the clinical range of 5–20 mg daily for hypogonadism. In non-medical contexts, 10 mg is sometimes considered a minimal dose, with 20 mg daily commonly referenced for strength peaking.
What strength is Halotestex 10 mg?
Halotestex 10 mg is labeled at 10 mg of fluoxymesterone per tablet. It is supplied as oral tablets in packs of 50 tablets manufactured by British Dragon.
Is Halotestex safe for the liver?
No. Fluoxymesterone is a 17α-alkylated androgen and is among the most hepatotoxic oral steroids. It is associated with cholestatic jaundice, elevated transaminases, and rarely hepatocellular neoplasms and peliosis hepatis. Even short-term use carries significant liver risk.
Related Offers
British Dragon Pharmaceuticals
Product Information
Compound Details
Active Substance
Nandrolone Decanoate
Long-Acting 19-Nor Anabolic-Androgenic Steroid
250 mg/mL
Strength
250 mg/mL
Package
10 mL Vial
2,500 mg Total Labeled Content
Form
Oil-Based Injectable
Drug Class
Anabolic-Androgenic Steroid
Estimated Half-Life
Approximately 6–12 Days
Manufacturer
British Dragon
British Dragon Pharmaceuticals
Product Information
Compound Details
Active Substance
Methandienone
Dianabol · 17α-Alkylated Oral Anabolic Steroid
10 / 20 / 50 mg
Strength
10, 20, or 50 mg/tablet
Package
100 Tablets
Form
Oral Tablets
Drug Class
Anabolic-Androgenic Steroid
Estimated Half-Life
Approximately 3–6 Hours
Manufacturer
British Dragon
British Dragon Pharmaceuticals
Product Information
Compound Details
Active Substance
Oxymetholone
17α-Alkylated Oral Anabolic Steroid
50 mg
Strength
50 mg/tablet
Package
50 Tablets
2,500 mg Total Labeled Content
Form
Oral Tablets
Drug Class
Anabolic-Androgenic Steroid
Estimated Half-Life
Approximately 8–9 Hours
Manufacturer
British Dragon
British Dragon Pharmaceuticals
Product Information Compound Details
Active Formula Cut Mix
150 mg/mLDrostanolone Propionate 50 mg
Testosterone Propionate 50 mg
Trenbolone Acetate 50 mg
Total Strength 150 mg/mL
Package 10 mL Vial 1,500 mg total labeled content
Form Oil-Based Injectable
Formula 3-Compound Cut Blend
Drug Class Androgen & Anabolic Steroid
Manufacturer British Dragon